{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:02:19Z","timestamp":1791259339320,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":2733,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/gim.2013.162","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T11:14:39Z","timestamp":1383822879000},"page":"435-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["A multicenter, open-label study evaluating safety and clinical outcomes in children (1.4\u20137.5 years) with Hunter syndrome receiving idursulfase enzyme replacement therapy"],"prefix":"10.1016","volume":"16","author":[{"given":"Roberto","family":"Giugliani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tylki-Szymanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.H.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Pano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/gim.2013.162_bb0010","author":"Meikle"},{"key":"10.1038\/gim.2013.162_bb0015","author":"Bach"},{"key":"10.1038\/gim.2013.162_bb0020","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses.","author":"Neufeld","year":"2001"},{"key":"10.1038\/gim.2013.162_bb0025","author":"Martin"},{"key":"10.1038\/gim.2013.162_bb0030","author":"Young"},{"key":"10.1038\/gim.2013.162_bb0035","unstructured":"Elaprase\u00ae (idursulfase) solution for intravenous infusion [prescribing information]. Shire Human Genetic Therapies: Cambridge, MA, 2011."},{"key":"10.1038\/gim.2013.162_bb0040","author":"Muenzer"},{"key":"10.1038\/gim.2013.162_bb0045","author":"Muenzer"},{"key":"10.1038\/gim.2013.162_bb0050","author":"Frankenburg"},{"key":"10.1038\/gim.2013.162_bb0055","unstructured":"US Department of Health and Human Services (US Food and Drug Administration). Code of Federal Regulations\u2013\u2013Title 21\u2013\u2013Food and Drugs. US Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfCFR\/CFRSearch.cfm. Accessed 1 May 2012."},{"key":"10.1038\/gim.2013.162_bb0060","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry Assay Development for Immunogenicity Testing of Therapeutic Proteins. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research: Rockville, MD, 2009."},{"key":"10.1038\/gim.2013.162_bb0065","unstructured":"Committee for Medicinal Products for Human Use. Guideline on Immunogenicity Assessment of Biotechnology-Derived Therapeutic Proteins (EMEA\/CHMP\/BMWP\/14327\/2006). European Medicines Agency: London, UK, 2007."},{"key":"10.1038\/gim.2013.162_bb0070","author":"de Jong"},{"key":"10.1038\/gim.2013.162_bb0075","unstructured":"Mayo Medical Laboratories. Mucopolysaccharides (MPS) Screen, Urine. Mayo Clinic: Andover, MA, 2012. http:\/\/www.mayomedicallaboratories.com\/test-catalog\/Overview\/84464. Accessed 28 March 2013."},{"key":"10.1038\/gim.2013.162_bb0080","author":"Gallegos-Arreola"},{"key":"10.1038\/gim.2013.162_bb0085","author":"Dittrich"},{"key":"10.1038\/gim.2013.162_bb0090","unstructured":"Centers for Disease Control and Prevention. Clinical Growth Charts. Centers for Disease Control and Prevention: Atlanta, GA, 2012. http:\/\/www.cdc.gov\/growthcharts\/clinical_charts.htm. Accessed 15 May 2012."}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/gim2013162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gim2013162","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021049030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021049030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gim2013162.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:44:38Z","timestamp":1761097478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021049030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1098360021049030"],"URL":"https:\/\/doi.org\/10.1038\/gim.2013.162","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter, open-label study evaluating safety and clinical outcomes in children (1.4\u20137.5 years) with Hunter syndrome receiving idursulfase enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/gim.2013.162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics","name":"copyright","label":"Copyright"}]}}